Psychometric properties of perceived barriers to PKU treatment inventory in a Brazilian national sample.

IF 3.5 2区 医学 Q2 GENETICS & HEREDITY
Katia Irie Teruya, Eduardo Remor, Ida Vanessa Doederlein Schwartz
{"title":"Psychometric properties of perceived barriers to PKU treatment inventory in a Brazilian national sample.","authors":"Katia Irie Teruya, Eduardo Remor, Ida Vanessa Doederlein Schwartz","doi":"10.1186/s13023-025-03998-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Metabolic control in the phenylketonuria (PKU) population is challenging. Perceived barriers to treatment adherence have been shown to be associated with metabolic control outcomes. The objective of this study was to evaluate the psychometric properties of the Perceived Barriers to PKU Treatment Inventory with patients and caregivers in different regions of Brazil.</p><p><strong>Methods: </strong>This is a cross-sectional, observational, non-probability sampling study. The inventory has 25 dichotomous items and two versions, patients and caregivers. Data collection in the present study included online assessment (n = 241) and presential mode (n = 42). Sixty-three PKU patients and 220 caregivers of individuals with PKU participated in this study. Internal consistency reliability, convergent validity, known-group validity, and discriminant validity of both versions (patient and proxy report) were evaluated. Furthermore, score norms based on the current sample are presented. A content analysis of the responses recorded in the open-ended inventory was also conducted.</p><p><strong>Results: </strong>Adequate reliability and evidence for convergent validity, known- groups validity, and discriminant validity were observed in this sample. Optimal cutoff points were identified through ROC curves (score > 9 for the patient version and score > 6 for the caregiver-proxy version), allowing for the identification of the risk of poor metabolic control due to barriers to dietary adherence. Furthermore, the qualitative analysis showed the relevance of the 25 items and the importance of addressing socio-economic and health system factors that have a significant economic impact on patients' and families' lives.</p><p><strong>Conclusion: </strong>The findings indicate that the Perceived Barriers to PKU Treatment Inventory is valuable for screening barriers that may contribute to increasing the difficulty of treatment management. And to identify patients and caregivers who may require targeted support to improve dietary adherence and metabolic control.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":19651,"journal":{"name":"Orphanet Journal of Rare Diseases","volume":"20 1","pages":"487"},"PeriodicalIF":3.5000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12461978/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orphanet Journal of Rare Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13023-025-03998-5","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Metabolic control in the phenylketonuria (PKU) population is challenging. Perceived barriers to treatment adherence have been shown to be associated with metabolic control outcomes. The objective of this study was to evaluate the psychometric properties of the Perceived Barriers to PKU Treatment Inventory with patients and caregivers in different regions of Brazil.

Methods: This is a cross-sectional, observational, non-probability sampling study. The inventory has 25 dichotomous items and two versions, patients and caregivers. Data collection in the present study included online assessment (n = 241) and presential mode (n = 42). Sixty-three PKU patients and 220 caregivers of individuals with PKU participated in this study. Internal consistency reliability, convergent validity, known-group validity, and discriminant validity of both versions (patient and proxy report) were evaluated. Furthermore, score norms based on the current sample are presented. A content analysis of the responses recorded in the open-ended inventory was also conducted.

Results: Adequate reliability and evidence for convergent validity, known- groups validity, and discriminant validity were observed in this sample. Optimal cutoff points were identified through ROC curves (score > 9 for the patient version and score > 6 for the caregiver-proxy version), allowing for the identification of the risk of poor metabolic control due to barriers to dietary adherence. Furthermore, the qualitative analysis showed the relevance of the 25 items and the importance of addressing socio-economic and health system factors that have a significant economic impact on patients' and families' lives.

Conclusion: The findings indicate that the Perceived Barriers to PKU Treatment Inventory is valuable for screening barriers that may contribute to increasing the difficulty of treatment management. And to identify patients and caregivers who may require targeted support to improve dietary adherence and metabolic control.

Clinical trial number: Not applicable.

Abstract Image

巴西国家样本中PKU治疗量表感知障碍的心理测量特性。
背景:苯丙酮尿症(PKU)人群的代谢控制具有挑战性。治疗依从性的感知障碍已被证明与代谢控制结果相关。本研究的目的是评估巴西不同地区患者和护理人员在PKU治疗量表中感知障碍的心理测量特性。方法:这是一项横断面、观察性、非概率抽样研究。该清单有25个二分项目和两个版本,患者和护理人员。本研究的数据收集包括在线评估(n = 241)和在场模式(n = 42)。63名PKU患者和220名PKU患者的护理人员参与了这项研究。评估两种版本(患者报告和代理报告)的内部一致性信度、收敛效度、已知组效度和判别效度。此外,给出了基于当前样本的得分规范。还对开放式问卷中记录的回答进行了内容分析。结果:本样本有足够的信度和证据证明趋同效度、已知组效度和区别效度。通过ROC曲线确定最佳截断点(患者版本为bbbb9分,护理者代理版本为bbbb6分),从而确定由于饮食依从性障碍而导致代谢控制不良的风险。此外,定性分析显示了这25个项目的相关性,以及解决对患者和家庭生活产生重大经济影响的社会经济和卫生系统因素的重要性。结论:研究结果表明,PKU治疗障碍感知量表对筛查可能增加治疗管理难度的障碍有价值。并确定可能需要有针对性的支持来改善饮食依从性和代谢控制的患者和护理人员。临床试验号:不适用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases 医学-医学:研究与实验
CiteScore
6.30
自引率
8.10%
发文量
418
审稿时长
4-8 weeks
期刊介绍: Orphanet Journal of Rare Diseases is an open access, peer-reviewed journal that encompasses all aspects of rare diseases and orphan drugs. The journal publishes high-quality reviews on specific rare diseases. In addition, the journal may consider articles on clinical trial outcome reports, either positive or negative, and articles on public health issues in the field of rare diseases and orphan drugs. The journal does not accept case reports.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信